Werz O et al.Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity.Nat Commun 9:59 (2018).
Garscha U et al.Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase.Sci Rep 7:9398 (2017).
Pace S et al.Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males.J Clin Invest 127:3167-3176 (2017).
Garscha U et al.BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.Biochem Pharmacol 119:17-26 (2016).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"